Morgane Mabire
Overview
Explore the profile of Morgane Mabire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mabire M, Gilgenkrantz H, Lotersztajn S
Med Sci (Paris)
. 2023 Sep;
39(8-9):591-593.
PMID: 37695142
No abstract available.
2.
Allaire M, Sayegh R, Mabire M, Hammoutene A, Siebert M, Caer C, et al.
JHEP Rep
. 2023 Jul;
5(8):100794.
PMID: 37520673
Background & Aims: Liver regeneration is a repair process in which metabolic reprogramming of parenchymal and inflammatory cells plays a major role. Monoacylglycerol lipase (MAGL) is an ubiquitous enzyme at...
3.
Mabire M, Hegde P, Hammoutene A, Wan J, Caer C, Sayegh R, et al.
Nat Commun
. 2023 Apr;
14(1):1830.
PMID: 37005415
Recent data have shown that liver fibrosis can regress even at later stages of cirrhosis and shifting the immune response from pro-inflammatory towards a resolutive profile is considered as a...
4.
Wan J, Weiss E, Ben Mkaddem S, Mabire M, Choinier P, Thibault-Sogorb T, et al.
Autophagy
. 2020 May;
16(8):1526-1528.
PMID: 32434445
Control of systemic and hepatic inflammation, in particular originating from monocytes/macrophages, is crucial to prevent liver fibrosis and its progression to end-stage cirrhosis. LC3-associated phagocytosis (LAP) is a non-canonical form...
5.
Wan J, Weiss E, Ben Mkaddem S, Mabire M, Choinier P, Picq O, et al.
Sci Transl Med
. 2020 Apr;
12(539).
PMID: 32295902
Sustained hepatic and systemic inflammation, particularly originating from monocytes/macrophages, is a driving force for fibrosis progression to end-stage cirrhosis and underlies the development of multiorgan failure. Reprogramming monocyte/macrophage phenotype has...
6.
Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver
Habib A, Chokr D, Wan J, Hegde P, Mabire M, Siebert M, et al.
Gut
. 2018 Oct;
68(3):522-532.
PMID: 30301768
Objective: Sustained inflammation originating from macrophages is a driving force of fibrosis progression and resolution. Monoacylglycerol lipase (MAGL) is the rate-limiting enzyme in the degradation of monoacylglycerols. It is a...
7.
Hegde P, Weiss E, Paradis V, Wan J, Mabire M, Sukriti S, et al.
Nat Commun
. 2018 Jun;
9(1):2146.
PMID: 29858567
Liver fibrosis is the common response to chronic liver injury, and leads to cirrhosis and its complications. Persistent inflammation is a driving force of liver fibrosis progression. Mucosal-associated invariant T...